Danziger Asaf has filed 21 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 1 shares of NovoCure Ltd ($NVCR) on December 31, 2025.
Activity breakdown: 0 open-market purchases and 10 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2025 | NovoCure Ltd | $NVCR | Danziger Asaf | Not found | A | Ordinary Shares | 1 | $10.99 | 416,474.0000 | 111,981,981 | 0.00% | 0.00% |
| June 30, 2025 | NovoCure Ltd | $NVCR | Danziger Asaf | Not found | A | Ordinary Shares | 833 | $15.13 | 416,473.0000 | 109,915,429 | 0.20% | 0.00% |
| Jan. 1, 2025 | NovoCure Ltd | $NVCR | Danziger Asaf | Not found | A | Ordinary Shares | 400000 | $0.00 | 415,640.0000 | 0 | 2557.55% | 0.00% |
| Dec. 31, 2024 | NovoCure Ltd | $NVCR | Danziger Asaf | Not found | A | Ordinary Shares | 412 | $14.75 | 15,640.0000 | 0 | 2.71% | 0.00% |
| June 28, 2024 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | A | Ordinary Shares | 1239 | $12.24 | 15,228.0000 | 0 | 8.86% | 0.00% |
| June 30, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | A | Ordinary Shares | 367 | $35.28 | 13,989.0000 | 0 | 2.69% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 8369 | $111.23 | 30,214.0000 | 0 | 21.69% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 2000 | $112.86 | 28,214.0000 | 0 | 6.62% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 4568 | $114.35 | 23,646.0000 | 0 | 16.19% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 3702 | $115.21 | 19,944.0000 | 0 | 15.66% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 1395 | $116.06 | 18,549.0000 | 0 | 6.99% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 999 | $117.01 | 17,550.0000 | 0 | 5.39% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 2123 | $118.47 | 15,427.0000 | 0 | 12.10% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 1344 | $119.35 | 14,083.0000 | 0 | 8.71% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 500 | $119.99 | 13,583.0000 | 0 | 3.55% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | M | Ordinary Shares | 187500 | $7.15 | 201,083.0000 | 0 | 1380.40% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | S | Ordinary Shares | 187500 | $108.00 | 13,583.0000 | 0 | 93.25% | 0.00% |
| Jan. 6, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | A | Ordinary Shares | 39 | $62.31 | 13,622.0000 | 0 | 0.29% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | M | Options to Buy Ordinary Shares | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | M | Options to Buy Ordinary Shares | 187500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 5, 2023 | NovoCure Ltd | $NVCR | Danziger Asaf | Chief Executive Officer | M | Ordinary Shares | 25000 | $11.46 | 38,583.0000 | 0 | 184.05% | 0.00% |